The best indicator for Incyte (INCY)
We backtested 20 indicators across daily, weekly and hourly charts on real Incyte (INCY) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Williams %R
On the weekly chart, this is the strongest risk-adjusted edge we found for Incyte (INCY) over ~32.7 years — beating buy-and-hold by 1.9% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Williams %R ✓ | Weekly | 14.7% | 0.53 | -80.0% | 76.6% | 47 | 1.9% |
| 2 | Heikin-Ashi Trend | Weekly | 14.3% | 0.51 | -70.8% | 46.3% | 298 | 1.4% |
| 3 | Bollinger Breakout | Daily | 11.7% | 0.5 | -67.9% | 45.8% | 142 | -1.4% |
| 4 | MACD ✓ | Daily | 12.7% | 0.49 | -87.7% | 41.3% | 288 | -0.4% |
| 5 | EMA-10 Trend | Weekly | 12.5% | 0.47 | -87.4% | 41.2% | 153 | -0.4% |
| 6 | MACD ✓ | Weekly | 11.9% | 0.46 | -88.9% | 47.3% | 55 | -1.0% |
| 7 | EMA 20/50 Cross | Daily | 10.0% | 0.44 | -86.4% | 35.4% | 79 | -3.0% |
| 8 | RSI Trend (>50) | Daily | 10.3% | 0.44 | -89.6% | 36.4% | 448 | -2.8% |
| 9 | RSI Trend (>50) ✓ | Weekly | 10.3% | 0.43 | -87.9% | 40.2% | 82 | -2.5% |
| 10 | EMA 20/50 Cross | Weekly | 8.6% | 0.4 | -87.8% | 33.3% | 18 | -4.3% |
| 11 | Donchian Midline ✓ | Weekly | 9.0% | 0.4 | -85.7% | 37.4% | 91 | -3.9% |
| 12 | Donchian Breakout | Daily | 7.9% | 0.39 | -69.3% | 36.9% | 122 | -5.2% |
| 13 | WaveTrend (8/6/4) ✓ | Weekly | 7.7% | 0.38 | -92.2% | 71.4% | 28 | -5.1% |
| 14 | Rate of Change | Daily | 7.1% | 0.37 | -92.8% | 43.2% | 533 | -5.9% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Incyte (INCY), Williams %R on the weekly timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.